Latest News - Amgen
Top Corporates Hub
Amgen
Piper Sandler Maintains Overweight on Amgen, Raises Price Target to $457
20.08.2026 12:24
Piper Sandler analyst David Amsellem maintains Amgen (NASDAQ:AMGN) with a Overweight and raises the price target from $427 to $457.
BeOne Medicines Ltd (ONC) (Q2 2026) Earnings Call Highlights: Revenue Surges 30% to $1. ...
13.08.2026 01:04
BeOne Medicines Ltd (ONC) delivers robust Q2 2026 results with record BRUKINSA sales, raises full-year guidance, and advances a promising oncology pipeline.
Guggenheim Maintains Neutral on Amgen, Raises Price Target to $388
10.08.2026 09:43
Guggenheim analyst Vamil Divan maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $343 to $388.
How to Build $13,000 a Month in Dividend Income From Three Income Buckets
10.08.2026 03:34
Reaching $13,000 a month in dividends sounds like a capital problem, but the real trap is choosing the wrong yield tier and watching income quietly erode while you sleep. Three buckets can get you there, each with a very different cost hiding beneath the headline number.
Amgen: The Market Is Underestimating Its Next Growth Phase
07.08.2026 10:51
Amgen stock update: Tezspire and Repatha sales are surging as 2026 revenue guidance rises. Click here to read more about AMGN.
Chubb, Toast And A Health Care Stock On CNBC’s ‘Final Trades’
07.08.2026 08:05
Bill Baruch chose Amgen Inc. as his final trade, citing its strong Q2 results and raised guidance. Malcolm Ethridge recommended Chubb.
Stock Market Today: Dow Rises, Nasdaq Slides As Tech Stocks Come Under Pressure; Uber Dives (Live Coverage)
05.08.2026 18:56
Stock Market Today: The Dow Jones index rises Wednesday with word on a Strait of Hormuz deal. AMD stock and SpaceX fall.
Amgen gains after strong quarterly results and continued product momentum
05.08.2026 17:25
Amgen Inc (NASDAQ:AMGN, XETRA:AMG) shares rose about 4% on Wednesday after the biotechnology company reported second quarter 2026 results that topped Wall Street expectations, supported by higher revenue and growth across its portfolio of medicines. The company reported adjusted earnings per...
Teva Pharmaceuticals: Continuing To Execute On Its 'Pivot To Growth' Plan
05.08.2026 16:05
Teva Pharmaceutical Industries Limited turnaround: Pivot to Growth, raised 2026 guidance, $3.7B specialty target, and more. Click for this TEVA update.
Amgen: First $10 Billion Quarter, More Growth Ahead
05.08.2026 14:21
Amgen Inc. Q2 beat lifts FY guidance despite LOE headwinds; see portfolio drivers, pipeline catalysts, and M&A limitsâclick to read the AMGN highlights now.
AMGN Q2 Earnings Call Centers on Raised Outlook and Pipeline
05.08.2026 14:00
Amgen raised its 2026 outlook as broad product growth funds a deeper late-stage pipeline push amid biosimilar pressure on older franchises.
Truist Securities Maintains Hold on Amgen, Raises Price Target to $362
05.08.2026 13:54
Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $340 to $362.
Amgen Q2 2026 earnings beat, raises full-year outlook, drops AMG 513
05.08.2026 13:22
The biotech raised its full-year revenue forecast to $38.2 billion–$39.4 billion after second-quarter revenue rose 10% to $10.1 billion
Oppenheimer Maintains Outperform on Amgen, Raises Price Target to $450
05.08.2026 13:16
Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $400 to $450.
Scotiabank Maintains Sector Outperform on Amgen, Raises Price Target to $450
05.08.2026 11:45
Scotiabank analyst Louise Chen maintains Amgen (NASDAQ:AMGN) with a Sector Outperform and raises the price target from $385 to $450.
RBC Capital Maintains Outperform on Amgen, Raises Price Target to $400
05.08.2026 11:37
RBC Capital analyst Luca Issi maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $370 to $400.
Wells Fargo Maintains Equal-Weight on Amgen, Raises Price Target to $400
05.08.2026 10:53
Wells Fargo analyst Mohit Bansal maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $390 to $400.
BMO Capital Maintains Outperform on Amgen, Raises Price Target to $450
05.08.2026 07:56
BMO Capital analyst Evan David Seigerman maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $400 to $450.
Amgen (AMGN) Lifted 2026 Guidance, Is The Valuation Still Too Rich?
05.08.2026 07:13
How Amgen’s latest earnings event sets the stage for investors Amgen (AMGN) just released its second quarter 2026 results, reporting revenue of US$10.05b and net income of US$2.38b, alongside updated full year guidance that gives investors fresh numbers to work with. For the first half of 2026, Amgen reported revenue of US$18.67b and net income of US$4.19b. Basic earnings per share from continuing operations were US$7.77, with diluted EPS at US$7.71 for the period. The company now expects...
Amgen Inc (AMGN) (Q2 2026) Earnings Call Highlights: Revenue Surges Past $10 Billion, Guidance ...
05.08.2026 05:06
Amgen Inc (AMGN) delivers 10% revenue growth driven by key products like Repatha and UPLIZNA, while raising full-year 2026 guidance.